WHO ICTRP trial
Randomized phase III trial on NIraparib-Dostarlimab vs physician’s choice…
CTIS2024-516649-38-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2024-516649-38-00 |
|---|---|
| Public title | Randomized phase III trial on NIraparib-Dostarlimab vs physician’s choice CHEmotherapy in recurrent, ovarian, fallopian tube or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO33) |
| Scientific title | Randomized phase III trial on NIraparib-Dostarlimab) vs physician’s choice CHEmotherapy in recurrent, ovarian, fallopian tube or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33) - MITO 33 |
| Primary sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): No |
| Countries | Czechia;France;Germany;Italy |
| Conditions | Recurrent ovarian, fallopian tube or primary peritoneal cancer;Therapeutic area: Diseases [C] - Neoplasms [C04] |
| Interventions | Product Name: , Product Code:SCP138158, Pharmaceutical Form: , Other descriptive name: , Strength: , Product Name: , Product Code:SCP1128788, Pharmaceutical Form: , Other descriptive name: , Strength: , Product Name: , Product… |
| Registration date | Jul 10, 2024 |
| Target size | 427 |
| Secondary IDs | 2020-000146-33 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: